These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of a single bout of strenuous exercise on platelet activation in female ApoE/LDLR Przyborowski K; Kassassir H; Wojewoda M; Kmiecik K; Sitek B; Siewiera K; Zakrzewska A; Rudolf AM; Kostogrys R; Watala C; Zoladz JA; Chlopicki S Platelets; 2017 Nov; 28(7):657-667. PubMed ID: 28067100 [TBL] [Abstract][Full Text] [Related]
4. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice. Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172 [TBL] [Abstract][Full Text] [Related]
5. TLR2 Plays a Key Role in Platelet Hyperreactivity and Accelerated Thrombosis Associated With Hyperlipidemia. Biswas S; Zimman A; Gao D; Byzova TV; Podrez EA Circ Res; 2017 Sep; 121(8):951-962. PubMed ID: 28775078 [TBL] [Abstract][Full Text] [Related]
6. Hyperlipidemia promotes thrombosis after injury to atherosclerotic vessels in apolipoprotein E-deficient mice. Eitzman DT; Westrick RJ; Xu Z; Tyson J; Ginsburg D Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1831-4. PubMed ID: 10894825 [TBL] [Abstract][Full Text] [Related]
7. Generation of hyperlipidemic rabbit models using multiple sgRNAs targeted CRISPR/Cas9 gene editing system. Yuan T; Zhong Y; Wang Y; Zhang T; Lu R; Zhou M; Lu Y; Yan K; Chen Y; Hu Z; Liang J; Fan J; Cheng Y Lipids Health Dis; 2019 Mar; 18(1):69. PubMed ID: 30885208 [TBL] [Abstract][Full Text] [Related]
8. Counteract of bone marrow of blotchy mice against the increases of plasma copper levels induced by high-fat diets in LDLR-/- mice. Yao J; Qin Z J Trace Elem Med Biol; 2015; 31():11-7. PubMed ID: 26004886 [TBL] [Abstract][Full Text] [Related]
12. Hyperlipidemia induces typical atherosclerosis development in Ldlr and Apoe deficient rats. Zhao Y; Yang Y; Xing R; Cui X; Xiao Y; Xie L; You P; Wang T; Zeng L; Peng W; Li D; Chen H; Liu M Atherosclerosis; 2018 Apr; 271():26-35. PubMed ID: 29459263 [TBL] [Abstract][Full Text] [Related]
13. Agonist-specific impairment of coronary vascular function in genetically altered, hyperlipidemic mice. Lamping KG; Nuno DW; Chappell DA; Faraci FM Am J Physiol; 1999 Apr; 276(4):R1023-9. PubMed ID: 10198381 [TBL] [Abstract][Full Text] [Related]
14. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease. Ravindran R; Krishnan LK Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614 [TBL] [Abstract][Full Text] [Related]
15. Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia. Gallagher EJ; Zelenko Z; Neel BA; Antoniou IM; Rajan L; Kase N; LeRoith D Oncogene; 2017 Nov; 36(46):6462-6471. PubMed ID: 28759039 [TBL] [Abstract][Full Text] [Related]
16. Hyperlipidemia is a major determinant of neointimal formation in LDL receptor-deficient mice. Tian J; Pei H; Sanders JM; Angle JF; Sarembock IJ; Matsumoto AH; Helm GA; Shi W Biochem Biophys Res Commun; 2006 Jul; 345(3):1004-9. PubMed ID: 16712797 [TBL] [Abstract][Full Text] [Related]